Get ready for an inspiring journey as we dive into the world of innovation and entrepreneurship! ArrayPatch's triumph at the 2025 Seedcorn Competition is a testament to the power of groundbreaking ideas. But here's where it gets controversial: is it the cash prize that matters most, or the validation and support these winners receive? Let's explore!
ArrayPatch, the overall winner, has developed an incredible technology called DerMap™, a microneedle marvel that delivers medication precisely where it's needed. By avoiding invasive treatments, they're revolutionizing the way we treat various conditions. And the best part? They've won a whopping €130,000 to invest in their vision!
But wait, there's more! The B2C category winner, Gigi Supplements, is on a mission to support female hormonal health with science-backed supplements. Founded by nutritional therapists, their debut product is already making waves. And with a €100,000 prize, they're ready to expand their reach.
In the B2B category, HaPPE Earth is tackling a critical environmental issue: single-use plastic PPE waste. Their fully compostable PPE solution is not just innovative, but also sustainable. And this win means they can take their business to new heights, offering a credible alternative to traditional plastics.
Now, let's talk about the Impact Award. Slice of Life, a Dublin-based food startup, is making healthy eating delicious and convenient. Their pizzas are a nutritional powerhouse, packing three of your five-a-day, and they're available in major retailers across Dublin. With a €20,000 prize, they're set to make an even bigger impact.
But here's the part most people miss: it's not just about the money. These winners have received invaluable support, mentorship, and access to investors throughout the competition. The Seedcorn process has sharpened their strategies and accelerated their growth trajectories.
Dr. Waleed Faisal, CEO of ArrayPatch, sums it up perfectly: "Becoming the overall Seedcorn winner validates our technology and vision. ArrayPatch aims to make therapies safer and more accessible, and this recognition showcases DerMap™'s potential to reshape drug delivery."
